November 14, 2025
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Patent Practitioners are Unsettled Regarding Seemingly-Settled Section 101 Jurisprudence
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Patent Practitioners are Unsettled Regarding Seemingly-Settled Section 101 Jurisprudence
Biotechnology

Patent Practitioners are Unsettled Regarding Seemingly-Settled Section 101 Jurisprudence

By Newsroom
Last updated: October 26, 2025
1 Min Read
Share


Patent eligibility under 35 U.S.C. § 101 should be a straightforward threshold question: any “new and useful process, machine, manufacture, or composition of matter” is eligible for protection. Yet over time, this once-clear principle has become anything but.

Although the statute itself has remained unchanged for two centuries, its interpretation has evolved dramatically through judicial decisions. And it is this common law precedent that has shaped the approach to the determination of patent subject matter eligibility.

Courts have carved out broad, judge-made exceptions to patentability, excluding laws of nature,…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

U.K. pilot creates hydrogen, graphene from wastewater biogas

Environmental Science
May 3, 2025

Ethical AI in Healthcare & Life Sciences

A pragmatic guide for CXOs in the healthcare and pharmaceutical industries Artificial intelligence is already…

November 13, 2025

As Part of the “AfriSummit 2024” Activities A High-Level Meeting between Uganda and Egypt to Strengthen Pharmaceutical Cooperation and Expand the African Market

A high-level meeting between Uganda and Egypt to strengthen pharmaceutical cooperation CAIRO, Egypt (AfricaNewswire.Net) —…

April 5, 2025

ضمن فعاليات “قمة إفريقيا للشؤون التنظيمية 2024” اجتماع رفيع بين أوغندا ومصر لتعزيز التعاون الدوائي وتوسيع السوق الإفريقية

اجتماع رفيع المستوى بين أوغندا ومصر لتعزيز التعاون الصيدلاني القاهرة، مصر، نوفمبر 2024 (AfricaNewswire.Net)  في…

April 5, 2025

YOU MAY ALSO LIKE

The Future of Marketing in the Biotechnology Industry: The Role of Press Release Distribution

The biotechnology industry is experiencing rapid advancements in gene editing, personalized medicine, synthetic biology, and biopharmaceuticals. As the industry expands,…

Biotechnology
April 9, 2025

AI, Algorithms and Abstract Ideas: Federal Circuit Reinforces Limits in Recentive v. Fox

In April, the Federal Circuit issued a significant patent law ruling involving artificial intelligence. In Recentive Analytics, Inc. v. Fox…

Biotechnology
June 27, 2025

Focus on Fintiv: Shift in Patent Office Guidance for Discretionary Denials of Patent Challenges

On February 28, 2025, the U.S. Patent and Trademark Office announced that it was rescinding a 2022 memorandum that provided…

Biotechnology
April 5, 2025

Federal Circuit Clarifies Limits of Issue Preclusion Between IPRs and District Courts

The Federal Circuit’s recent decision last week in Inland Diamond Prods. Co. v. Cherry Optical Inc., offers an important reminder…

Biotechnology
November 2, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Ethical AI in Healthcare & Life Sciences
November 13, 2025
How to Avoid GMP Audit Failures
November 13, 2025
From patient data to novel targets and biomarkers: UK Biobank…
November 13, 2025
Study Rescue: Stabilize, Accelerate, Deliver
November 13, 2025

Life Science Magazines

Ethical AI in Healthcare & Life Sciences
November 13, 2025
How to Avoid GMP Audit Failures
November 13, 2025
From patient data to novel targets and biomarkers: UK Biobank…
November 13, 2025
Study Rescue: Stabilize, Accelerate, Deliver
November 13, 2025

LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?